S&P/ASX 200 Index (ASX: XJO) shares hit a 15-week low before closing at 8,665 points on Friday, down 0.76% for the week.
Here's how John Athanasiou from Red Leaf Securities rates these three ASX 200 heavyweights (courtesy of The Bull).

Image source: Getty Images
CSL Ltd (ASX: CSL)
The CSL share price rose 0.77% last week to close at $176.95 on Friday.
Athanasiou has a buy rating on this ASX 200 healthcare share.
He said:
CSL's recovery is gaining momentum after forecasting underlying profit growth guidance of about 5 per cent in fiscal year 2027. Guidance exceeded market expectations.
Immunoglobulin sales improved in the second half of fiscal year 2026 amid the company announcing a further share buy-back of $1.1 billion.
The outlook for this global health care company is improving after prolonged underperformance.
CSL shares have risen from $92.24 on June 3 to trade at $179.19 on September 24.
Successfully meeting or exceeding its targets leaves room for a potentially higher share price considering the stock was trading above $300 in calendar year 2024.
BHP Group Ltd (ASX: BHP)
The BHP share price fell 0.54% last week to close at $60.72 on Friday.
Athanasiou has a hold rating on this ASX 200 mining share.
He explained:
BHP remains a high quality, diversified resources company, supported by iron ore and increasing exposure to copper.
However, a softer global growth outlook and uncertainty surrounding Chinese commodity demand limit the case for aggressively buying the stock at this point.
Existing investors can continue holding for its balance sheet strength, dividends and long term copper exposure.
Copper contributed 54 per cent of group underlying EBITDA in full year 2026.
Commonwealth Bank of Australia (ASX: CBA)
The Commonwealth Bank share price fell 1.05% last week to finish at $150.83 on Friday.
Athanasiou has a sell rating on this ASX 200 bank share.
He said:
CBA is Australia's highest quality major bank, but, in my view, quality doesn't always represent value.
Its premium valuation leaves limited room for disappointment as rising interest rates potentially slow credit growth and increase borrower stress.
Investors could use the opportunity to take profits and consider better-value alternatives elsewhere in the banking sector.